about
Management of ampullary neoplasms: A tailored approach between endoscopy and surgerySelection criteria in resectable pancreatic cancer: a biological and morphological approachExtent of Surgery and Implications of Transection Margin Status after Resection of IPMNsEnhanced recovery pathways in pancreatic surgery: State of the artManagement of neuroendocrine carcinomas of the pancreas (WHO G3): A tailored approach between proliferation and morphologySystematic review and meta-analysis on laparoscopic pancreatic resections for neuroendocrine neoplasms (PNENs).Systematic review and meta-analysis of metal versus plastic stents for preoperative biliary drainage in resectable periampullary or pancreatic head tumors.Long-term outcome after laparoscopic bowel resections for deep infiltrating endometriosis: a single-center experience after 900 casesImpact of Ki67 re-assessment at time of disease progression in patients with pancreatic neuroendocrine neoplasms.Molecular pathology of intraductal papillary mucinous neoplasms of the pancreas.Delayed gastric emptying after pylorus-preserving pancreaticoduodenectomy: validation of International Study Group of Pancreatic Surgery classification and analysis of risk factors.Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics.Invasive intraductal papillary mucinous carcinomas of the pancreas: predictors of survival and the role of lymph node ratioPancreaticojejunostomy is comparable to pancreaticogastrostomy after pancreaticoduodenectomy: an updated meta-analysis of randomized controlled trials.Systematic review of active surveillance versus surgical management of asymptomatic small non-functioning pancreatic neuroendocrine neoplasms.Evaluation of an enhanced recovery protocol after pancreaticoduodenectomy in elderly patientsAlteration in emergency theatre prioritisation does not alter outcome for acute appendicitis: comparative cohort study.Time trends in the treatment and prognosis of resectable pancreatic cancer in a large tertiary referral centre.Parenchyma-sparing resections for pancreatic neoplasms.Surgical treatment of pancreatic tumors in childhood and adolescence: uncommon neoplasms with favorable outcome.Current status of robotic distal pancreatectomy: a systematic review.Pattern and clinical predictors of lymph node involvement in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs).A systematic review on robotic pancreaticoduodenectomy.Surgical management of pancreatic neuroendocrine neoplasms.Portal vein embolization and ligation for extended hepatectomyRight hemicolectomy plus pancreaticoduodenectomy vs partial duodenectomy in treatment of locally advanced right colon cancer invading pancreas and/or only duodenum.GEP-NETS update: a review on surgery of gastro-entero-pancreatic neuroendocrine tumors.Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinoma.A systematic review and meta-analysis of spleen-preserving distal pancreatectomy with preservation or ligation of the splenic artery and vein.Ki-67 prognostic and therapeutic decision driven marker for pancreatic neuroendocrine neoplasms (PNENs): A systematic review.Surgical management of neuroendocrine tumors.Assessing the role of primary tumour resection in patients with synchronous unresectable liver metastases from pancreatic neuroendocrine tumour of the body and tail. A propensity score survival evaluation.Multimodal treatment of resectable pancreatic ductal adenocarcinoma.mTOR inhibitors response and mTOR pathway in pancreatic neuroendocrine tumors.Malignant pancreatic neuroendocrine tumour: lymph node ratio and Ki67 are predictors of recurrence after curative resections.Active Surveillance versus Surgery of Nonfunctioning Pancreatic Neuroendocrine Neoplasms ≤2 cm in MEN1 Patients.Risk of misdiagnosis and overtreatment in patients with main pancreatic duct dilatation and suspected combined/main-duct intraductal papillary mucinous neoplasms.Long-term outcomes and prognostic factors in neuroendocrine carcinomas of the pancreas: Morphology matters.Resection of the Primary Tumor Followed by Peptide Receptor Radionuclide Therapy as Upfront Strategy for the Treatment of G1-G2 Pancreatic Neuroendocrine Tumors with Unresectable Liver Metastases.Is there a role for surgical resection in patients with pancreatic cancer with liver metastases responding to chemotherapy?
P50
Q26799743-B19D22F6-D7C7-4347-8F29-709D44819423Q26859742-5CB46472-AAD3-4C4C-9E36-A327FE27B683Q26991981-BD0A7C9D-856B-4DB9-A883-63D3F7241E81Q28073870-D5F5288D-1F1E-444E-9FA9-508BFB82815CQ28078501-90F8602C-C165-470A-B40D-75F279684A5EQ30244079-97352971-61F5-4EB2-8E59-0C8DE4B97A1AQ30249649-4B17549A-01EA-414F-A935-5FD9D8572E0EQ33615621-5A9DC287-3AD7-4545-B8B8-1B69CA2E51AEQ33828850-D5E41B3B-8243-499C-9906-8BDA47296FE5Q34008627-0EB6A8E4-376F-4791-A6D2-C7AB1782BE5DQ34394446-60371853-1CFF-450C-8354-5EC7E2128250Q35102198-78062F15-8E07-4D8F-A15D-F14F1AE485D8Q35102376-292AF19C-7ACF-4BF8-A270-9DD8E2CE4646Q35996487-C9A809E7-E55E-49ED-A025-901C1027D9B9Q36154116-CAE35961-4216-434C-BE07-B0ADBBFF539BQ36747296-9C166D50-2891-44AB-9F0D-F6F108E403DEQ37238502-C1E1C576-70C3-4FFC-A883-57EC19395E8AQ37350310-1AFD6C1F-B727-49BC-A53A-DEA3BF411F9DQ37623489-056CB8B2-1AC3-415F-AC98-43A80D211991Q37926865-BC502E8F-635D-4AE6-B79B-18123887F32BQ38126218-990712D6-987E-4094-8AED-082B7DAC154AQ38132363-3FC76E0C-3117-4B0B-AC4E-17F62D6A1801Q38141342-D02D3B7D-F5CE-4C7D-868C-AFE2B372912DQ38198509-0A77A528-9158-4497-AB8E-052E707D6553Q38199484-E75720E7-4C3F-42ED-80E9-EBFEC6723AE8Q38204113-F04EA018-B6F1-4EC2-B17C-3F452D7C3592Q38219613-D24B57A0-0DFA-46FB-9D97-FAB79207DB40Q38665086-CE261866-E735-4403-A85A-FB0E70BC43B2Q38684816-49E3FAE8-D1FB-4027-903D-6BFCF8177CC9Q38698815-70914DA6-A009-48F8-AC3F-7FDB876D223AQ38772481-6A28924A-BDC0-4111-9E72-77523BB85715Q38811556-7A9DBC65-DDA5-4F2D-A5DA-335ADB171702Q39161424-78DD9C50-07C3-48AE-9A14-1B86DFF6A797Q39327049-716FBB11-6830-4FE1-A474-B0DA18B646DAQ39681051-D8C18E1B-3DD4-4822-99BF-4B3773E28A6FQ40144879-32628CA6-E854-4E93-A1D1-FB88F675C182Q40171005-BE440E54-BC2C-40F1-B429-E12A1CB82B82Q40279719-7CBE2472-AF7B-448C-AB76-EF320385A92BQ40587447-0B7B7BA1-65FF-4BF7-94E4-580199C78F31Q40648311-44F4F3A9-9F02-421D-9ABF-7275AFD73DE0
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Stefano Partelli
@ast
Stefano Partelli
@en
Stefano Partelli
@es
Stefano Partelli
@nl
Stefano Partelli
@sl
type
label
Stefano Partelli
@ast
Stefano Partelli
@en
Stefano Partelli
@es
Stefano Partelli
@nl
Stefano Partelli
@sl
prefLabel
Stefano Partelli
@ast
Stefano Partelli
@en
Stefano Partelli
@es
Stefano Partelli
@nl
Stefano Partelli
@sl
P1053
K-3787-2018
P106
P1153
16687107300
P21
P31
P3829
P496
0000-0001-8938-6170